Ibutilide
Potentially Fatal Arrhythmias
Experienced Personnel/Equipped Facility
Potentially Fatal Arrhythmias: have occurred and requires administration in a setting of continuous ECG monitoring and personnel trained in identification and treatment of acute ventricular arrhythmias.
Patient Selection: Patients with chronic atrial fibrillation have a strong tendency to revert after conversion to sinus rhythm and treatment to maintain sinus rhythms carry risks. Patients for ibutilide therapy should be carefully selected.
MONITORING RECOMMENDATIONS RELATED TO BLACK BOX DATA
- Patients with atrial fibrillation of > 2 to 3 days must be adequately anticoagulated for > 2 weeks
- Assess benefit/risk ratio of maintenance therapy
Patient Counseling Information
Package Inserts
Additional Information
Updated January 2018